Nav: Home

New study: Leading cause of blindness could be prevented or delayed

November 09, 2015

Clarksburg MD - In a major scientific breakthrough, a drug used to treat Parkinson's and related diseases may be able to delay or prevent macular degeneration, the most common form of blindness among older Americans.

The findings, published in the American Journal of Medicine, are a groundbreaking effort in the fight against age-related macular degeneration (AMD), which affects as many as 11 million Americans. AMD hinders central vision, and even when it does not lead to blindness it can severely reduce the ability to read, drive, and recognize faces.

In the study, supported in part by BrightFocus Foundation, researchers discovered a biological connection between darker pigmented eyes, which are known to be resistant to AMD, and increased levels of a chemical called L-DOPA in those eyes. Since L-DOPA is frequently prescribed for Parkinson's patients, the researchers wanted to know whether patients who received the drug L-DOPA as treatment for Parkinson's or other diseases were protected from AMD. By combing through massive databases of medical chart data, they reported that patients receiving L-DOPA were significantly less likely to get AMD, and when they did, its onset was significantly delayed.

"Rather than looking at what might cause AMD, we instead wondered why certain people are protected from AMD. This approach had never been done before," says senior author Brian McKay of the University of Arizona.

The research findings are based off an analysis of the medical records of 37,000 patients at the Marshfield Clinic in Wisconsin. Because the average age of those given L-DOPA is 67, while the average age of AMD diagnosis is 71, scientists were able to effectively track patterns. These major findings were then confirmed by reviewing a data set of 87 million patients. In this large scale data set, L-DOPA also delayed or prevented AMD from progressing to its "wet" form, the most devastating form of the disease.

"This exciting breakthrough shows the power of scientific discovery to give hope to millions of people across the nation and the world. Their methodology is a reminder that 'big data' is not a buzzword - it is a bold and innovative new approach to science," said BrightFocus president and CEO Stacy Pagos Haller.

The next steps for the team of scientists is to launch a clinical trial to further test the ability of this drug to prevent AMD. The title of their research paper is "Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration."
-end-
BrightFocus Foundation drives innovative research worldwide and promotes awareness of Alzheimer's, macular degeneration, and glaucoma. BrightFocus, which earlier this year announced a record $11 million in new science to cure diseases of mind and sight, is currently managing a global portfolio of over 150 research projects. For more information http://www.BrightFocus.org or 800/437-2423.

BrightFocus Foundation

Related Blindness Articles:

Scientists pinpoint brain coordinates for face blindness
Danish and Norwegian researchers have moved one step closer to understanding where face blindness stems from in the brain.
Protein closely linked to commonest cause of blindness
An international team of scientists has identified a protein which is strongly linked to the commonest cause of blindness in developed countries when its levels are raised in the blood.
New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.
Treatments for leading cause of blindness generate $0.9 to $3 billion
A new economic study, published in JAMA Ophthalmology and conducted by USC researchers at the Schaeffer Center for Health Policy & Economics, the Ginsburg Institute for Biomedical Therapeutics, and the Roski Eye Institute, quantifies the benefits of treatment for wAMD.
Identifying a gene for canine night blindness
An international team of researchers led by the University of Pennsylvania's Keiko Miyadera has identified the gene mutation responsible for a form of night blindness in dogs.
Poor diet can lead to blindness
An extreme case of 'fussy' or 'picky' eating caused a young patient's blindness, according to a new case report published today [2 Sep 2019] in Annals of Internal Medicine.
Brighter possibilities for treating blindness
Advances in preclinical research are now being translated into innovative clinical solutions for blindness, a review published in the 10th anniversary series of science Translational Medicine depicts.
How blindness shapes sound processing
Adults who lost their vision at an early age have more refined auditory cortex responses to simple sounds than sighted individuals, according to new neuroimaging research published in JNeurosci.
Study identifies new genes associated with the leading cause of blindness
A new study, published in Clinical Epigenetics, identifies genes associated with Age-related Macular Degeneration (AMD) that could represent new targets for future drug development.
Diabetes medication may protect against a common cause of blindness
Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration (AMD).
More Blindness News and Blindness Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#566 Is Your Gut Leaking?
This week we're busting the human gut wide open with Dr. Alessio Fasano from the Center for Celiac Research and Treatment at Massachusetts General Hospital. Join host Anika Hazra for our discussion separating fact from fiction on the controversial topic of leaky gut syndrome. We cover everything from what causes a leaky gut to interpreting the results of a gut microbiome test! Related links: Center for Celiac Research and Treatment website and their YouTube channel
Now Playing: Radiolab

The Flag and the Fury
How do you actually make change in the world? For 126 years, Mississippi has had the Confederate battle flag on their state flag, and they were the last state in the nation where that emblem remained "officially" flying.  A few days ago, that flag came down. A few days before that, it coming down would have seemed impossible. We dive into the story behind this de-flagging: a journey involving a clash of histories, designs, families, and even cheerleading. This show is a collaboration with OSM Audio. Kiese Laymon's memoir Heavy is here. And the Hospitality Flag webpage is here.